Try our Advanced Search for more refined results
Health
Health Law360 provides breaking legal news and analysis on the health care industry. Coverage includes litigation, policy developments, and corporate deals involving health care services companies such as hospitals, health insurers, physicians groups, and medical suppliers.
Sign up for a 7-day FREE trial today!
Latest News in Health
-
December 23, 2025
Trump Admin Beats Chamber Suit Over $100K H-1B Visa Fee
A Washington, D.C., federal judge on Tuesday refused to block the Trump administration's new $100,000 H-1B visa fee, ruling in the U.S. Chamber of Commerce's lawsuit challenging the fee that President Donald Trump has "broad authority" to restrict noncitizens' entry.
-
December 23, 2025
Top Illinois Decisions Of 2025
State and federal courts have handed down rulings in Illinois cases this year that made clear plaintiffs must allege concrete injury for common law standing, narrowed the scope of the federal anti-kickback statute and laid out a new standard for certifying collective actions.
-
December 23, 2025
Philly Joins MDL Against Drug Cos., PBMs Over Insulin Prices
Philadelphia on Tuesday sued drug manufacturers Eli Lilly, Novo Nordisk and Sanofi, along with several pharmacy benefit managers, joining multidistrict litigation in New Jersey federal court accusing the companies of illegally inflating the price of insulin.
-
December 23, 2025
Full 9th Circ. Won't Hear Ex-Theranos Exec Balwani's Appeal
A Ninth Circuit panel rejected ex-Theranos executive Ramesh "Sunny" Balwani's en banc hearing request to reconsider his 12-count conviction and nearly 13-year prison sentence, while also amending its opinion to clarify that there was "ample evidence" to convict Balwani, even if prosecutors failed to correct a witness's testimony.
-
December 23, 2025
Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'
Amarin Pharma Inc. on Tuesday urged the U.S. Supreme Court to reject the U.S. solicitor general's call to hear a patent case involving generic drug "skinny labels," saying the dispute over the company's heart drug Vascepa deals with factual issues not suitable for high court review.
Areas of Coverage
- AGENCIES
- U.S. Department of Health and Human Services
- Centers for Medicare and Medicaid Services
- State and international health care regulators
- POLICY & REGULATION
- Affordable Care Act
- Health Insurance Portability and Accountability Act
- Patient’s Bill of Rights
- Stark Law
- Consumer protection controls
- Tax-related issues
- Health care lobbying
- State and international health care legislation and regulation
- ENFORCEMENT
- Health care fraud investigations
- Merger reviews
- LITIGATION
- Medical malpractice and liability suits
- Mass torts
- Health care fraud disputes
- Insurance coverage suits
- Reimbursement disputes
- Whistleblower and anti-corruption compliance suits
- Antitrust suits
- Breach of contract suits
- Labor and employment issues
- Shareholder disputes
- Bankruptcy proceedings
- TRANSACTIONS
- Mergers, acquisitions, and joint ventures
- Health care project finance and real estate deals
- PROFILES
- Personnel moves
- Profiles of health attorneys
Readership
- Health care lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the health care services industry
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals